62
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase

, , , , , , , , , , , & show all
Pages 623-630 | Published online: 21 Apr 2016

References

  • Orriach GuerreroJLRamirez FernandezAIglesiasPPreoperative levosimendan. A new way for organoprotectionCurr Pharm Des201420345476548324669969
  • du ToitEFGenisAOpieLHPolleselloPLochnerAA role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heartBr J Pharmacol20081541415018297097
  • TritapepeLDe SantisVVitaleDLevosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgeryBr J Anaesth2009102219820419151048
  • LevinRDegrangeMDel MazoCTanusEPorcileRPreoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypassExp Clin Cardiol201217312513023620700
  • Guerrero-OriachJLNavarro-ArceIIglesiasPGalán-OrtegaMRubio-NavarroMCruz MañasJPreoperative levosimendan for right ventricular dysfunction before heart valve replacement surgeryRev Esp Cardiol20136612999100024774116
  • CampoAMathaiSCLe PavecJOutcomes of hospitalisation for right heart failure in pulmonary arterial hypertensionEur Respir J201138235936721310884
  • SztrymfBSouzaRBertolettiLPrognostic factors of acute heart failure in patients with pulmonary arterial hypertensionEur Respir J20103561286129319897557
  • ErsoyOBoysanEUnalEUEffectiveness of prophylactic levosimendan in high-risk valve surgery patientsCardiovasc J Afr201324726026424217302
  • Rubio-RegidorMPérez-VelaJLEscribá-BárcenaANeurological complications in cardiac surgery post-operative periodMed Intensiva200731524125017580015
  • KarkoutiKWijeysunderaDNYauTMAcute kidney injury after cardiac surgery: focus on modifiable risk factorsCirculation2009119449550219153273
  • HaaseMBellomoRDevarajanPNovel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adultsAnn Thorac Surg200988112413019559209
  • BragadottirGRedforsBRickstenSEEffects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled studyCrit Care Med201341102328233523921271
  • VarvarousiGStefaniotouAVarvaroussisDAroniFXanthosTThe role of Levosimendan in cardiopulmonary resuscitationEur J Pharmacol201474059660224972240
  • KelmRFWagenführerJBauerHSchmidtmannIEngelhardKNoppensRREffects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in ratsCrit Care Med2014426e410e41924633188
  • ThakarCVArrigainSWorleySYaredJPPaganiniEPA clinical score to predict acute renal failure after cardiac surgeryJ Am Soc Nephrol200516116216815563569
  • RoquesFMichelPGoldstoneARNashefSAThe logistic Euro-SCOREEur Heart J200324882883
  • MehtaRLKellumJAShahSVAcute kidney injury network (AKIN): report of an initiative to improve outcomes in acute kidney injuryCrit Care2007112R3117331245
  • ParissisJTAdamopoulosSAntoniadesCEffects of levosimendan on circulating pro-inflammatory cytokynes and soluble apoptosis mediators in patients with decompensated advanced heart failureAm J Cardiol200493101309131215135713
  • PappZÉdesIFruhwaldSLevosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendanInt J Cardiol20121592828721784540
  • FijalkowskaAKurzynaMTorbickiASerum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertensionChest200612951313132116685024
  • ThakarCVWorleySArrigainSYaredJPPaganiniEPInfluence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal functionKidney Int20056731112111915698452
  • SearJWKidney dysfunction in the postoperative periodBr J Anaesth2005951203215531622
  • TuladharSMPüntmannVOSoniMPunjabiPPBogleRGRapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypassJ Cardio-vasc Pharmacol2009533261266
  • PrabhuASujathaDINinanBVijayalakshmiMANeutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypassAnn Vasc Surg201024452553120363104
  • CardosoJSFerreiraJde SáEPLevosimendan in daily intensive care practice – the experience of 15 centers. The PORTLAND studyJ Cardiac Fail200410131
  • LevinRLDegrangeMAPorcileRThe calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndromeRev Esp Cardiol200861547147918462650
  • McCullyDLevitskySMitochondrial ATP-sensitive potassium channels in surgical cardioprotectionArch Biochem Biophys200342023724514654062
  • PappJGPolleselloPVarróAFVéghASEffect of levosimendan and-milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogsJ Cardiovasc Pharmacol Ther200611212913516891290
  • MetzschCLiaoQSteenSAlgotssonLLevosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig modelActa Anaesthesiol Scand2007511869317073861
  • ParissisJTParaskevaidisIBistolaVEffects of levosimendan on right ventricular function in patients with advanced heart failureAm J Cardiol200698111489149217126656
  • PoelzlGZwickRHGranderWSafety and effectiveness of levosimendan in patients with predominant right heart failureHerz200833536837318773157
  • RussMAProndzinskyRCarterJMRight ventricular function in myocardial infarction complicated by cardiogenic shock: improvement with levosimendanCrit Care Med200937123017302319661807
  • HerrmannMEbertADGalazkyIWunderlichMTKunzWSHuthCNeurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissueStroke200031364565010700498
  • GaoFHarrisDNSapsed-ByrneSTime course of neuronespecific enolase and S-100 protein release during and after coronary artery bypass graftingBr J Anaesth199982226626710365005
  • KatirciogluSFSerenMParlarAILevosimendan effect on spinal cord ischemia-reperfusion injury following aortic clampingJ Card Surg2008231444818290886
  • LafciBYasaHIlhanGProtection of the spinal cord from ischemia: comparative effects of levosimendan and iloprostEur Surg Res20084111718354255
  • RoehlABHeinMLoetscherPDNeuroprotective properties of levosimendan in an in vitro model of traumatic brain injuryBMC Neurol2010109720964834
  • MayanagiKGáspárTKatakamPVBusijaDWSystemic administration of diazoxide induces delayed preconditioning against transient focal cerebral ischemia in ratsBrain Res2007116810611117706941
  • BantelCMazeMTrappSNeuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channelsAnesthesiology20091109598699519352153
  • SpongaSIvanitskaiaEPotapovEKrabatschTHetzerRLehmkuhlHPreoperative treatment with levosimendan in candidates for mechanical circulatory supportASAIO J201258161122157071
  • Guerrero OrriachJLGalán OrtegaMRamírez FernandezAAssessing the effect of preoperative levosimendan on renal function in patients with right ventricular dysfunctionJ Clin Monit Comput Epub1132016
  • YilmazMBGrossiniESilva CardosoJCRenal effects of levosimendan: a consensus reportCardiovasc Drugs Ther201327658159023929366